To determine if the pharmacokinetic parameters (AUC and Cp_max) after the test and the reference products are comparable.

To establish bioequivalence; the calculated 90% confidence intervals for the ratio of the average log-transformed AUC and Cp_max should fall within 80-125%. Products with confidence intervals that fall outside this range are not considered bioequivalent.